{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:43:35Z","timestamp":1781649815837,"version":"3.54.5"},"reference-count":32,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,3,1]],"date-time":"2008-03-01T00:00:00Z","timestamp":1204329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2008,3]]},"DOI":"10.1016\/j.atherosclerosis.2007.03.015","type":"journal-article","created":{"date-parts":[[2007,4,26]],"date-time":"2007-04-26T13:03:09Z","timestamp":1177592589000},"page":"154-158","source":"Crossref","is-referenced-by-count":48,"title":["Remarkable increase of apolipoprotein B48 level in diabetic patients with end-stage renal disease"],"prefix":"10.1016","volume":"197","author":[{"given":"Toshiyuki","family":"Hayashi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsutomu","family":"Hirano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayasu","family":"Taira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Tokuno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusaku","family":"Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinji","family":"Koba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuru","family":"Adachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2007.03.015_bib1","unstructured":"United States Renal Data System. USRDS 1998 annual data report, excerpts from V and VI. J Kidney Dis 1998;2(Suppl 1):S69\u201380, S81\u20138."},{"key":"10.1016\/j.atherosclerosis.2007.03.015_bib2","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/0021-9150(83)90045-X","article-title":"Analysis of cardiovascular risk factors in chronic hemodialysis patients with special attention to the hyperlipoproteinemias","volume":"48","author":"Hahn","year":"1983","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2007.03.015_bib3","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1046\/j.1523-1755.2000.00173.x","article-title":"Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients","volume":"58","author":"Cheung","year":"2000","journal-title":"Kidney Int"},{"key":"10.1016\/j.atherosclerosis.2007.03.015_bib4","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1001\/archinte.160.8.1093","article-title":"The risk of cardiovascular disease mortality associated with microalbuminuria and gross proteinuria in persons with older-onset diabetes mellitus","volume":"160","author":"Valmadrid","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.atherosclerosis.2007.03.015_bib5","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1093\/ndt\/13.11.2833","article-title":"The compositional abnormalities of lipoproteins in diabetic renal failure","volume":"13","author":"Attman","year":"1998","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.atherosclerosis.2007.03.015_bib6","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1046\/j.1523-1755.1999.07106.x","article-title":"Lipoprotein abnormalities in diabetic nephropathy","volume":"71","author":"Hirano","year":"1999","journal-title":"Kidney Int"},{"key":"10.1016\/j.atherosclerosis.2007.03.015_bib7","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1007\/BF00274218","article-title":"Coronary heart disease in young Type1 (insulin-dependent) diabetic patients with and without diabetic nephropathy: incidence and risk factors","volume":"30","author":"Jensen","year":"1987","journal-title":"Diabetologia"},{"key":"10.1016\/j.atherosclerosis.2007.03.015_bib8","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1007\/s001250050806","article-title":"High prevalence of risk factors for cardiovascular disease in parents of IDDM patients with albuminuria","volume":"40","author":"De Cosmo","year":"1997","journal-title":"Diabetologia"},{"key":"10.1016\/j.atherosclerosis.2007.03.015_bib9","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.2337\/diacare.21.11.2016","article-title":"Decreased release of lipoprotein lipase is associated with vascular endothelial damage in NIDDM patients with microalbuminuria","volume":"21","author":"Kashiwazaki","year":"1998","journal-title":"Diab Care"},{"key":"10.1016\/j.atherosclerosis.2007.03.015_bib10","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1046\/j.1523-1755.2003.00019.x","article-title":"Very low-density lipoprotein-apoprotein CI is increased in diabetic nephropathy: comparison with apoprotein CIII","volume":"63","author":"Hirano","year":"2003","journal-title":"Kidney Int"},{"key":"10.1016\/j.atherosclerosis.2007.03.015_bib11","doi-asserted-by":"crossref","first-page":"132","DOI":"10.5551\/jat.10.132","article-title":"Induction of atherosclerosis by human chylomicron remnants: a hypothesis","volume":"10","author":"Wilhelm","year":"2003","journal-title":"J Atheroscler Thromb"},{"key":"10.1016\/j.atherosclerosis.2007.03.015_bib12","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1161\/01.ATV.0000143859.75035.5a","article-title":"Arterial permeability and efflux of apolipoprotein B-containing lipoproteins assessed by in situ perfusion and three-dimensional quantitative confocal microscopy","volume":"24","author":"Proctor","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2007.03.015_bib13","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1161\/01.ATV.0000084638.14534.0A","article-title":"Intimal retention of cholesterol derived from apolipoprotein B100- and apolipoprotein B48-containing lipoproteins in carotid arteries of Watanabe heritable hyperlipidemic rabbits","volume":"23","author":"Proctor","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2007.03.015_bib14","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1515\/CCLM.2003.120","article-title":"Identification of lipoproteins of intestinal origin in human atherosclerotic plaque","volume":"41","author":"Pal","year":"2003","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.atherosclerosis.2007.03.015_bib15","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1042\/bst0320079","article-title":"Chylomicron metabolism","volume":"32","author":"Redgrave","year":"2004","journal-title":"Biochem Soc Trans"},{"key":"10.1016\/j.atherosclerosis.2007.03.015_bib16","doi-asserted-by":"crossref","first-page":"7488","DOI":"10.1073\/pnas.120184097","article-title":"A macrophage receptor for apolipoprotein B48: cloning, expression and atherosclerosis","volume":"97","author":"Brown","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.atherosclerosis.2007.03.015_bib17","doi-asserted-by":"crossref","first-page":"32228","DOI":"10.1074\/jbc.M204053200","article-title":"Identification of the proteoglycan binding site in apolipoprotein B48","volume":"277","author":"Flood","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.atherosclerosis.2007.03.015_bib18","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1194\/jlr.M300090-JLR200","article-title":"Measurement of fasting serum apoB-48 levels in normolipidemic and hyperlipidemic subjects by ELISA","volume":"44","author":"Sakai","year":"2003","journal-title":"J Lipid Res"},{"key":"10.1016\/j.atherosclerosis.2007.03.015_bib19","article-title":"Fasting apolipoprotein B48 levels measured by a novel ELISA are a simple and useful marker for postprandial hyperlipidemia and predict coronary heart disease","volume":"17","author":"Sakai","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2007.03.015_bib20","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0021-9150(98)00150-6","article-title":"High prevalence of small dense LDL in diabetic nephropathy is not directly associated with kidney damage: a possible role of postprandial lipemia","volume":"141","author":"Hirano","year":"1998","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2007.03.015_bib21","first-page":"439","article-title":"The influence of diabetic nephropathy on remnant lipoproteins","volume":"42","author":"Sakaue","year":"1999","journal-title":"J Jpn Diab Soc"},{"issue":"223","key":"10.1016\/j.atherosclerosis.2007.03.015_bib22","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0009-8981(93)90062-9","article-title":"Cholesterol in remnant-like lipoproteins in human serum using monoclonal anti apo B-100 and anti apo A\u2013I immunoaffinity mixed gels","volume":"31","author":"Nakajima","year":"1993","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.atherosclerosis.2007.03.015_bib23","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.atherosclerosis.2004.12.045","article-title":"22. Diurnal and acute patterns of postprandial apolipoprotein B-48 in VLDL, IDL, and LDL from normolipidemic humans","volume":"181","author":"Campos","year":"2005","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2007.03.015_bib24","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.atherosclerosis.2004.02.003","article-title":"Apolipoprotein B-48: comparison of fasting concentrations measured in normolipidaemic individuals using SDS-PAGE, immunoblotting and ELISA","volume":"176","author":"Jackson","year":"2004","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2007.03.015_bib25","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1038\/ki.1992.411","article-title":"Severe defect in clearing postprandial chylomicron remnants in dialysis patients","volume":"42","author":"Weintraub","year":"1992","journal-title":"Kidney Int"},{"key":"10.1016\/j.atherosclerosis.2007.03.015_bib26","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1111\/j.1523-1755.2005.00166.x","article-title":"Down-regulation of hepatic LDL receptor-related protein (LRP) in chronic renal failure","volume":"67","author":"Kim","year":"2005","journal-title":"Kidney Int"},{"key":"10.1016\/j.atherosclerosis.2007.03.015_bib27","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1038\/ki.1996.515","article-title":"Down-regulation of tissue lipoprotein lipase expression in experimental chronic renal failure","volume":"50","author":"Vaziri","year":"1996","journal-title":"Kidney Int"},{"key":"10.1016\/j.atherosclerosis.2007.03.015_bib28","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1194\/jlr.M300459-JLR200","article-title":"The bridging function of hepatic lipase clears plasma cholesterol in LDL receptor-deficient \u201capoB-48-only\u201d and \u201capoB-100-only\u201d mice","volume":"45","author":"Dichek","year":"2004","journal-title":"J Lipid Res"},{"key":"10.1016\/j.atherosclerosis.2007.03.015_bib29","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0022-2275(20)30142-5","article-title":"Properties of triglyceride-rich and cholesterol-rich lipoproteins in the remnant-like particle fraction of human blood plasma","volume":"43","author":"Campos","year":"2002","journal-title":"J Lipid Res"},{"key":"10.1016\/j.atherosclerosis.2007.03.015_bib30","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1161\/01.ATV.0000222015.76038.14","article-title":"Hyperinsulinemia is associated with increased production rate of intestinal apolipoprotein B-48-containing lipoproteins in humans","volume":"26","author":"Duez","year":"2006","journal-title":"Atheroscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2007.03.015_bib31","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1016\/j.metabol.2005.05.008","article-title":"Fasting apo B48 level and coronary artery disease in a population without frank fasting hypertriglyceridemia","volume":"54","author":"Valero","year":"2005","journal-title":"Metabolism"},{"key":"10.1016\/j.atherosclerosis.2007.03.015_bib32","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0021-9150(94)90085-X","article-title":"Postprandial lipoproteins and progression of coronary atherosclerosis","volume":"106","author":"Karpe","year":"1994","journal-title":"Atherosclerosis"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915007001694?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915007001694?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,8,12]],"date-time":"2021-08-12T22:34:33Z","timestamp":1628807673000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915007001694"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,3]]}},"alternative-id":["S0021915007001694"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2007.03.015","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2008,3]]}}}